Patent Limits For Biosimilar Litigation Lands In Spending Bill
By Dani Kass · December 18, 2024, 9:28 PM EST
Congress' spending package to keep the government open through March would also limit how many patents a biologics maker can assert when trying to prevent a competitor from getting on the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login